Security key
38942Q202
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 3,547,369
- Total 13F value
- $14,756,693
- Share change
- +3,030,591
- SEC-reported price per share
- $4.16
- Number of holders
- 19
- Value change
- +$12,607,257
- Number of buys
- 14
- Shares outstanding
- 35,825,367
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
19
Top holders
10
CALC full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
CalciMedica, Inc. SEC filings
CalciMedica, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 38942Q202
Recent filing periods:
Ownership snapshot
Top reported holders of CALC - CalciMedica, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ORBIMED ADVISORS LLC
Disclosed value leader
Sanderling Venture Partne...
Comparable rows
11/15
Latest evidence
23 Jan 2024
13F
3/4/5
Lead comparable stake: 0.83%
4 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
ORBIMED ADVISORS LLC leads the comparable SEC ownership view at 0.83%.
11 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ORBIMED ADVISORS LLC's linked filing trail.
Comparable ownership
Top 5
ORBIMED ADVISORS LLC
0.83%
BML Capital Management, LLC
0.41%
MERITAGE PORTFOLIO MANAGEMENT
0.13%
GEODE CAPITAL MANAGEMENT, LLC
0.04%
FIRST MANHATTAN CO. LLC.
0.04%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
Company
|
0.83%
|
$850,507
297,380 shares
|
— | 31 Dec 2023 |
| BML Capital Management, LLC |
13F
Company
|
0.41%
|
$415,913
145,424 shares
|
— | 31 Dec 2023 |
| MERITAGE PORTFOLIO MANAGEMENT |
13F
Company
|
0.13%
|
$132,000
46,000 shares
|
— | 31 Dec 2023 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.04%
|
$38,192
13,354 shares
|
— | 31 Dec 2023 |
| FIRST MANHATTAN CO. LLC. |
13F
Company
|
0.04%
|
$37,826
13,226 shares
|
— | 31 Dec 2023 |
| Tower Research Capital LLC (TRC) |
13F
Company
|
0%
|
$7,085
1,417 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
19
Shares
3,547,369
Rows available
19
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q3 2025 Across Filers
Q3 2025 holders
31
Q1 2024 holders
19
Holder diff
-12
| Investor | Q3 2025 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q3 2025 value | Q1 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend